1. Home
  2. MRK vs MS Comparison

MRK vs MS Comparison

Compare MRK & MS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$119.51

Market Cap

268.7B

Sector

Health Care

ML Signal

HOLD

Logo Morgan Stanley

MS

Morgan Stanley

HOLD

Current Price

$163.77

Market Cap

278.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRK
MS
Founded
2000
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
268.7B
278.4B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
MRK
MS
Price
$119.51
$163.77
Analyst Decision
Buy
Buy
Analyst Count
14
14
Target Price
$123.21
$176.00
AVG Volume (30 Days)
11.1M
7.1M
Earning Date
05-05-2026
01-01-0001
Dividend Yield
2.80%
2.40%
EPS Growth
8.01
N/A
EPS
7.28
N/A
Revenue
$65,011,000,000.00
N/A
Revenue This Year
$3.66
$12.04
Revenue Next Year
$5.28
$5.39
P/E Ratio
$16.69
$17.30
Revenue Growth
1.31
N/A
52 Week Low
$75.40
$94.33
52 Week High
$125.14
$192.68

Technical Indicators

Market Signals
Indicator
MRK
MS
Relative Strength Index (RSI) 53.97 38.27
Support Level $76.90 $155.22
Resistance Level N/A $167.41
Average True Range (ATR) 2.62 6.18
MACD -0.57 -0.88
Stochastic Oscillator 38.90 15.42

Price Performance

Historical Comparison
MRK
MS

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

About MS Morgan Stanley

Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 82,000 employees as of year-end 2025. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $9.3 trillion in client assets at the end of its most recent fiscal year. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with more than $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.

Share on Social Networks: